Results 101 to 110 of about 27,203 (237)

The Possible Role of Metformin and Fibroblast Growth Factor‐21 in Multiple Sclerosis Neuropathology: Birds of a Feather Flock Together

open access: yesEuropean Journal of Neuroscience, Volume 61, Issue 7, April 2025.
Predisposing factors of multiple sclerosis and Role of Metformin and Fibroblast Growth Factor‐21: A key predisposing factor for multiple sclerosis (MS) is genetic susceptibility, which is associated with an increased risk of the disease. Environmental factors, such as low vitamin D levels, smoking, and viral infections, also contribute to the ...
Ahmad A. Abulaban   +7 more
wiley   +1 more source

Robotic Thymectomy for Myasthenia Gravis: Analysis of the Surgical and Neurological Outcomes After a 20 Years' Experience

open access: yesEuropean Journal of Neurology, Volume 32, Issue 4, April 2025.
ABSTRACT Background Evidence supporting robotic thymectomy for myasthenia gravis is generally based on small sample‐size studies, heterogeneous in patient selection and in reporting outcomes. Therefore, this study was conducted to assess the surgical and neurological outcomes of robotic thymectomy in myasthenic patients and to identify prognostic ...
Giovanni M. Comacchio   +19 more
wiley   +1 more source

Brain‐Derived Tau as an Outcome Marker in Guillain‐Barré Syndrome: A Retrospective Cohort Study

open access: yesEuropean Journal of Neurology, Volume 32, Issue 4, April 2025.
ABSTRACT Background and Objectives Biomarkers for predicting disease severity and outcome in Guillain‐Barré syndrome (GBS) are scarce. We aimed to determine if brain‐derived tau in serum (sBD‐tau) and cerebrospinal fluid (CSF BD‐tau) are associated with long‐term outcome and disease severity in GBS.
Brynhildur Hafsteinsdóttir   +10 more
wiley   +1 more source

New Scenarios in Liver Transplantation for Hepatocellular Carcinoma

open access: yesLiver International, Volume 45, Issue 4, April 2025.
ABSTRACT Background and Aims Despite liver transplantation (LT) is considered the optimal treatment for hepatocellular carcinoma (HCC), particularly in patients with impaired liver function, the shortage of donors has forced the application of very restrictive criteria for selecting ideal candidates for whom LT can offer the best outcome.
Ezequiel Mauro   +8 more
wiley   +1 more source

Impact of therapeutic plasmapheresis on the duration of organ failure in patients with hypertriglyceridemia-associated acute pancreatitis

open access: yesAnnals of Intensive Care
Background Plasmapheresis is widely used for severe hypertriglyceridemia-associated acute pancreatitis (HTG-AP) to remove excessive triglycerides from plasma. This study aimed to evaluate whether plasmapheresis could improve the duration of organ failure
Lanting Wang   +16 more
doaj   +1 more source

Perioperative Therapeutic Plasmapheresis [PDF]

open access: yesAnesthesiology, 2013
Sloan C. Youngblood   +3 more
openaire   +3 more sources

Exchange transfusion and pre‐filter apheresis dilution for hyperviscosity syndrome refractory to conventional therapeutic plasma exchange in a patient with IgA multiple myeloma

open access: yesTransfusion, Volume 65, Issue 4, Page 779-784, April 2025.
Abstract Background Significant serum paraprotein elevation leading to hyperviscosity syndrome (HVS) is a rare but serious medical complication that has been well documented in patients with hematological malignancies, including multiple myeloma and Waldenström's macroglobulinemia.
Anthony Valin‐Thorburn   +7 more
wiley   +1 more source

Immunoadsorbent plasmapheresis for a patient with antiphospholipid syndrome during pregnancy. [PDF]

open access: bronze, 1992
S Kobayashi   +5 more
openalex   +1 more source

Home - About - Disclaimer - Privacy